0 Комментарии
0 Поделились
56 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Courses
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Breakthroughs in Friedreich’s Ataxia Treatment: From Hope to Reality1. Introduction: Friedreich’s Ataxia Friedreich’s ataxia (FRDA) is a rare inherited neurodegenerative disorder that affects the nervous system and heart. It is caused by a GAA trinucleotide repeat expansion in the FXN gene on chromosome 9, leading to reduced production of frataxin, a mitochondrial protein vital for iron–sulfur (Fe–S) cluster formation. This deficiency...0 Комментарии 0 Поделились 575 Просмотры 0 предпросмотр
-
Friedreich’s Ataxia Market Overview: Growth, Share, Value, Size, and ScopeIntroduction Friedreich’s Ataxia is a rare, inherited neurodegenerative disorder that primarily affects the nervous system and heart, leading to progressive loss of coordination, muscle weakness, speech difficulties, and cardiomyopathy. Caused by mutations in the FXN gene, the disease typically manifests in childhood or adolescence and worsens over time, significantly impacting...0 Комментарии 0 Поделились 379 Просмотры 0 предпросмотр
-
Friedreich’s Ataxia Market Size: Growth, Share, Value, Trends, and Analysis"Global Demand Outlook for Executive Summary Friedreich’s Ataxia Market Size and Share The global Friedreich’s Ataxia market size was valued at USD 2.63 billion in 2024 and is expected to reach USD 3.59 billion by 2032, at a CAGR of 4.00% during the forecast period. For a constantly increasing business growth and maximum return on investment...0 Комментарии 0 Поделились 776 Просмотры 0 предпросмотр